| MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma. | MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma.
Huang P, Zhao H, Sun R, Liu C, Wu L, Wang Y, Gan Z, Yang X, Du J., Free PMC Article | 08/13/2024 |
| Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas. | Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas.
Chen Z, Ruan W, Guo C, Chen K, Li L, Tian J, Hu Z, Peng D, Zeng X., Free PMC Article | 07/13/2023 |
| An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer. | An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer.
Liu Y, Ma X, Feng L, Lin Z, Zhou X. | 01/21/2023 |
| NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability. | NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability.
Kim JH, Youn Y, Hwang JH., Free PMC Article | 12/10/2022 |
| NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma. | NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma.
Li C, Meng J, Zhang T., Free PMC Article | 06/18/2022 |
| NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. | NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
Li B, Xiao Q, Shan L, Song Y., Free PMC Article | 04/23/2022 |
| NCAPH regulates gastric cancer progression through DNA damage response. | NCAPH regulates gastric cancer progression through DNA damage response.
Wang Y, Li JQ, Yang ZL, Wang L, Zhang JC, Sun YF, Li ZY, Qin L. | 04/16/2022 |
| miR-133b targets NCAPH to promote beta-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer. | miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer.
Xiong Q, Jiang L, Liu K, Jiang X, Liu B, Shi Y, Cheng D, Duan Y, Yang C, Chen Y., Free PMC Article | 03/26/2022 |
| NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics. | NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X, Gao Z, Shao J, Li H. | 07/3/2021 |
| Identification of NCAPH as a biomarker for prognosis of breast cancer. | Identification of NCAPH as a biomarker for prognosis of breast cancer.
Lu H, Shi C, Wang S, Yang C, Wan X, Luo Y, Tian L, Li L. | 05/22/2021 |
| NCAPH is negatively associated with Mcl1 in nonsmall cell lung cancer. | NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.
Xiong Q, Fan S, Duan L, Liu B, Jiang X, Chen X, Xiong C, Tao Q, Wang J, Zhang H, Chen C, Duan Y., Free PMC Article | 05/8/2021 |
| HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. | HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
Wang M, Qiao X, Cooper T, Pan W, Liu L, Hayball J, Lin J, Cui X, Zhou Y, Zhang S, Zou Y, Zhang R, Wang X., Free PMC Article | 04/13/2021 |
| Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH. | Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC, Wang J, Cheng Y, Zhang XY, Ye XQ. | 11/28/2020 |
| miR-199a/b-3p was significantly downregulated in metastatic castration-resistant compared with hormone-sensitive prostate cancer tissues. Ectopic expression of miR-199a/b inhibited cancer cell aggressiveness. The gene coding for NCAPH was directly regulated by miR-199a/b-3p. High expression of NCAPH was significantly associated with poor disease-free survival by The Cancer Genome Atlas database analysis. | Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N. | 07/18/2020 |
| NCAPH knockdown inhibited cell proliferation, induced cell-cycle arrest at G2/M phase, and prevented colony formation, migration and invasion by NSCLC cells. | NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells.
Kim B, Kim SW, Lim JY, Park SJ. | 07/18/2020 |
| Findings indicate that non-SMC condensing I complex subunit H (NCAPH) could serve as a prognostic biomarker and a potential therapeutic target for patients with hepatocellular carcinoma (HCC). | Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
Sun C, Huang S, Wang H, Xie R, Zhang L, Zhou Q, He X, Ju W., Free PMC Article | 02/8/2020 |
| NCAPH high expression promotes colonic cancerous cell proliferation. | NCAPH plays important roles in human colon cancer.
Yin L, Jiang LP, Shen QS, Xiong QX, Zhuo X, Zhang LL, Yu HJ, Guo X, Luo Y, Dong J, Kong QP, Yang CP, Chen YB., Free PMC Article | 10/28/2017 |
| Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death. | Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death.
Lai SK, Wong CH, Lee YP, Li HY., Free PMC Article | 08/27/2011 |
| Our results identify a SSB-specific response of condensin I through PARP-1 and demonstrate a role for condensin in SSB. repair. | Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair.
Heale JT, Ball AR Jr, Schmiesing JA, Kim JS, Kong X, Zhou S, Hudson DF, Earnshaw WC, Yokomori K., Free PMC Article | 01/21/2010 |